Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.

Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Wong R, Huang A, Misra S, Schwartz M, Mitrani R, Nakka S, Noureddine W, Ho C, Konjeti VR, Dao A, Nelson K, Delarosa K, Rahim U, Mavuram M, Xie JJ, Murphy CC, Parikh ND.

Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30057-5. doi: 10.1053/j.gastro.2019.01.027. [Epub ahead of print]

PMID:
30660729
2.

Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.

Costiniuk CT, Nitulescu R, Saneei Z, Wasef N, Salahuddin S, Wasef D, Young J, de Castro C, Routy JP, Lebouché B, Cox J, Smith BM, Ambroise S, Pexos C, Patel M, Szabo J, Haraoui LP, de Pokomandy A, Tsoukas C, Falutz J, LeBlanc R, Giannakis A, Frenette C, Jenabian MA, Bourbeau J, Klein MB.

HIV Med. 2019 Mar;20(3):192-201. doi: 10.1111/hiv.12699. Epub 2019 Jan 8.

PMID:
30620136
3.

Increasing Awareness on Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States.

Frenette CT.

Hepatol Commun. 2019 Jan 1;3(1):5-7. doi: 10.1002/hep4.1299. eCollection 2019 Jan.

4.

Trapped vessel of abdominal pain with hepatomegaly: A case report.

Grandhe S, Lee JA, Chandra A, Marsh C, Frenette CT.

World J Hepatol. 2018 Nov 27;10(11):887-891. doi: 10.4254/wjh.v10.i11.887.

5.

Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct-Acting Antivirals for Hepatitis C.

Pan JJ, Bao F, Du E, Skillin C, Frenette CT, Waalen J, Alaparthi L, Goodman ZD, Pockros PJ.

Hepatol Commun. 2018 Sep 21;2(11):1320-1330. doi: 10.1002/hep4.1228. eCollection 2018 Nov.

6.

A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated Cirrhosis.

Mehta G, Rousell S, Burgess G, Morris M, Wright G, McPherson S, Frenette C, Cave M, Hagerty DT, Spada A, Jalan R.

J Clin Exp Hepatol. 2018 Sep;8(3):224-234. doi: 10.1016/j.jceh.2017.11.006. Epub 2017 Nov 22.

7.

A ten-year review of healthcare-associated bloodstream infections from forty hospitals in Québec, Canada.

Fakih I, Fortin É, Smith MA, Carignan A, Tremblay C, Villeneuve J, Moisan D, Frenette C, Quach C; for SPIN-BACTOT.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1202-1209. doi: 10.1017/ice.2018.185. Epub 2018 Aug 29.

PMID:
30156168
8.

Hepatocellular cancer pain: impact and management challenges.

Christian-Miller N, Frenette C.

J Hepatocell Carcinoma. 2018 Jul 19;5:75-80. doi: 10.2147/JHC.S145450. eCollection 2018. Review.

9.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).

Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T, Evans GA, Frenette C, Gravel D, Hota S, Kibsey P, Langley JM, Lee BE, Lemieux C, Longtin Y, Mertz D, Mieusement LMD, Minion J, Moore DL, Mulvey MR, Richardson S, Science M, Simor AE, Stagg P, Suh KN, Taylor G, Wong A, Thampi N; Canadian Nosocomial Infection Surveillance Program.

CMAJ. 2018 Jun 25;190(25):E758-E765. doi: 10.1503/cmaj.180013.

10.

Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo.

Frenette CT, Morelli G, Shiffman ML, Frederick RT, Rubin RA, Fallon MB, Cheng JT, Cave M, Khaderi SA, Massoud O, Pyrsopoulos N, Park JS, Robinson JM, Yamashita M, Spada AP, Chan JL, Hagerty DT.

Clin Gastroenterol Hepatol. 2018 Jun 18. pii: S1542-3565(18)30622-0. doi: 10.1016/j.cgh.2018.06.012. [Epub ahead of print]

11.

Angiocentric lymph proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a case report.

Costiniuk CT, Karamchandani J, Bessissow A, Routy JP, Szabo J, Frenette C.

BMC Infect Dis. 2018 May 8;18(1):210. doi: 10.1186/s12879-018-3128-3.

12.

Health Care-Associated Infections after Subarachnoid Hemorrhage.

Abulhasan YB, Alabdulraheem N, Schiller I, Rachel SP, Dendukuri N, Angle MR, Frenette C.

World Neurosurg. 2018 Jul;115:e393-e403. doi: 10.1016/j.wneu.2018.04.061. Epub 2018 Apr 18.

PMID:
29678711
13.

Healthcare-associated infections in the neurological intensive care unit: Results of a 6-year surveillance study at a major tertiary care center.

Abulhasan YB, Rachel SP, Châtillon-Angle MO, Alabdulraheem N, Schiller I, Dendukuri N, Angle MR, Frenette C.

Am J Infect Control. 2018 Jun;46(6):656-662. doi: 10.1016/j.ajic.2017.12.001. Epub 2018 Feb 1.

PMID:
29395511
14.

Hypoalbuminemia is Associated With Significantly Higher Liver Transplant Waitlist Mortality and Lower Probability of Receiving Liver Transplant.

Ahn J, Sundaram V, Ayoub WS, Frenette C, Wong RJ.

J Clin Gastroenterol. 2018 Nov/Dec;52(10):913-917. doi: 10.1097/MCG.0000000000000984.

PMID:
29356783
15.

Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study.

Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, Roberts JP, Yao FY.

Clin Gastroenterol Hepatol. 2018 Jun;16(6):955-964. doi: 10.1016/j.cgh.2017.11.037. Epub 2017 Nov 23.

PMID:
29175528
16.

Multiplex Respiratory Virus Testing for Antimicrobial Stewardship: A Prospective Assessment of Antimicrobial Use and Clinical Outcomes Among Hospitalized Adults.

Semret M, Schiller I, Jardin BA, Frenette C, Loo VG, Papenburg J, McNeil SA, Dendukuri N.

J Infect Dis. 2017 Nov 15;216(8):936-944. doi: 10.1093/infdis/jix288.

17.

A rare localised nasal CD30+ primary cutaneous T-cell lymphoma following liver transplantation.

Nhu QM, Du EZ, Kiyani A, Frenette CT.

BMJ Case Rep. 2017 Nov 4;2017. pii: bcr-2017-221028. doi: 10.1136/bcr-2017-221028.

19.

Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.

Bogaty C, Lévesque S, Garenc C, Frenette C, Bolduc D, Galarneau LA, Lalancette C, Loo V, Tremblay C, Trudeau M, Vachon J, Dionne M, Villeneuve J, Longtin J, Longtin Y; Quebec Clostridium difficile Infection Surveillance Program (QCISP).

Am J Infect Control. 2017 Sep 1;45(9):964-968. doi: 10.1016/j.ajic.2017.04.002. Epub 2017 May 23.

PMID:
28549882
20.

Epidemiology and outcome of antimicrobial resistance to gram-negative pathogens in bacteriuric kidney transplant recipients.

Delmas-Frenette C, Dorais M, Tavares-Brum A, Frenette C, Yang B, Medani S, Duclos A, Rouleau D, Mawad H, Barama A, Cardinal H.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12722. Epub 2017 Jul 3.

PMID:
28486744
21.

The Role of Regorafenib in Hepatocellular Carcinoma.

Frenette CT.

Gastroenterol Hepatol (N Y). 2017 Feb;13(2):122-124. No abstract available.

22.

The role of regorafenib in hepatocellular carcinoma.

Frenette CT.

Clin Adv Hematol Oncol. 2017 Feb;15(2):121-123. Review. No abstract available.

PMID:
28398282
23.

Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC).

Abou-Alfa GK, Yen CJ, Hsu CH, O'Donoghue J, Beylergil V, Ruan S, Pandit-Taskar N, Gansukh B, Lyashchenko SK, Ma J, Wan P, Shao YY, Lin ZZ, Frenette C, O'Neil B, Schwartz L, Smith-Jones PM, Ohtomo T, Tanaka T, Morikawa H, Maki Y, Ohishi N, Chen YC, Agajanov T, Boisserie F, Di Laurenzio L, Lee R, Larson SM, Cheng AL, Carrasquilo JA.

Cancer Chemother Pharmacol. 2017 Feb;79(2):421-429. doi: 10.1007/s00280-017-3241-9. Epub 2017 Jan 24.

24.

Novel second-line treatments for hepatocellular carcinoma: Discussion.

Frenette CT, Lencioni R, Finn RS.

Clin Adv Hematol Oncol. 2016 Dec;14 Suppl 12(12):12-13. No abstract available.

PMID:
27930619
25.

Second-line therapy for patients with hepatocellular carcinoma.

Frenette CT.

Clin Adv Hematol Oncol. 2016 Dec;14 Suppl 12(12):3-5. No abstract available.

PMID:
27930616
26.

Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma.

Nhu QM, Knowles H, Pockros PJ, Frenette CT.

World J Respirol. 2016;6(3):69-75. Epub 2016 Nov 28.

27.

Evaluating the impact of the multiplex respiratory virus panel polymerase chain reaction test on the clinical management of suspected respiratory viral infections in adult patients in a hospital setting.

Yee C, Suarthana E, Dendukuri N, Nicolau I, Semret M, Frenette C.

Am J Infect Control. 2016 Nov 1;44(11):1396-1398. doi: 10.1016/j.ajic.2016.04.221. Epub 2016 Jun 13.

PMID:
27311514
28.

Impact of an Infection Control and Antimicrobial Stewardship Program on Solid Organ Transplantation and Hepatobiliary Surgical Site Infections.

Frenette C, Sperlea D, Leharova Y, Thirion DJ.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1468-1474. Epub 2016 Oct 3.

PMID:
27692005
29.

Surveillance for Hepatocellular Carcinoma.

Frenette C.

Gastroenterol Hepatol (N Y). 2016 Jun;12(6):394-6. No abstract available.

30.

Older Patients With Hepatocellular Carcinoma Have More Advanced Disease, Lower Rates of Treatment, and Lower Survival.

Yan M, Ha J, Aguilar M, Liu B, Frenette CT, Bhuket T, Wong RJ.

J Clin Gastroenterol. 2017 Apr;51(4):378-383. doi: 10.1097/MCG.0000000000000590.

PMID:
27380460
31.

Surveillance for hepatocellular carcinoma.

Frenette C.

Clin Adv Hematol Oncol. 2016 Jun;14(6):407-9. No abstract available.

PMID:
27379808
32.

End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.

Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ.

Hepatol Int. 2016 Sep;10(5):838-46. doi: 10.1007/s12072-016-9735-4. Epub 2016 May 24.

PMID:
27221700
33.

Influence of a 5-year serial infection control and antibiotic stewardship intervention on cardiac surgical site infections.

Frenette C, Sperlea D, Tesolin J, Patterson C, Thirion DJ.

Am J Infect Control. 2016 Sep 1;44(9):977-82. doi: 10.1016/j.ajic.2016.02.029. Epub 2016 Apr 25.

PMID:
27125912
34.

An Unexpected Pulmonary Complication Following Transcatheter Arterial Chemoembolization of a Small Hepatocellular Carcinoma.

Nhu QM, Knowles H, Pockros PJ, Frenette CT.

J Clin Gastroenterol. 2016 Jul;50(6):524-5. doi: 10.1097/MCG.0000000000000524. No abstract available.

35.

Is blood donation an opportunity for hypertension awareness?

Hao J, McAvoy J, Wickberg L, Kerrigan C, Kreiger L, Sikavi C, Swift D, Frenette C, Carney J, Fung MK.

Transfus Med. 2016 Apr;26(2):89-98. doi: 10.1111/tme.12286. Epub 2016 Mar 21.

PMID:
26996380
36.

Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.

Simor AE, Pelude L, Golding G, Fernandes R, Bryce E, Frenette C, Gravel D, Katz K, McGeer A, Mulvey MR, Smith S, Weiss K; Canadian Nosocomial Infection Surveillance Program.

Infect Control Hosp Epidemiol. 2016 Apr;37(4):390-7. doi: 10.1017/ice.2015.323. Epub 2016 Jan 19.

PMID:
26782274
37.

Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.

Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ.

J Clin Gastroenterol. 2016 May-Jun;50(5):423-30. doi: 10.1097/MCG.0000000000000448.

PMID:
26583267
38.

Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.

Brown RS Jr, O'Leary JG, Reddy KR, Kuo A, Morelli GJ, Burton JR Jr, Stravitz RT, Durand C, Di Bisceglie AM, Kwo P, Frenette CT, Stewart TG, Nelson DR, Fried MW, Terrault NA; Hepatitis C Therapeutic Registry Research Network Study Group.

Liver Transpl. 2016 Jan;22(1):24-33. doi: 10.1002/lt.24366.

39.

Erratum: Management of Hepatocellular Carcinoma: Current Status and Future Directions.

Au JS, Frenette CT.

Gut Liver. 2015 Nov 23;9(6):811. doi: 10.5009/gnl15000. No abstract available.

40.

Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma.

Bhangoo MS, Karnani DR, Hein PN, Giap H, Knowles H, Issa C, Steuterman S, Pockros P, Frenette C.

J Gastrointest Oncol. 2015 Oct;6(5):469-78. doi: 10.3978/j.issn.2078-6891.2015.056.

41.

Bacteremia caused by a mecA-positive oxacillin-susceptible Staphylococcus aureus strain with inducible resistance.

Kong LY, Jean A, Wong H, Semret M, Frenette C, Simor AE, Fenn S, Loo VG.

Diagn Microbiol Infect Dis. 2015 Dec;83(4):377-8. doi: 10.1016/j.diagmicrobio.2015.09.001. Epub 2015 Sep 4. No abstract available.

PMID:
26422086
42.

Epidemiological features of influenza in Canadian adult intensive care unit patients.

Taylor G, Abdesselam K, Pelude L, Fernandes R, Mitchell R, McGeer A, Frenette C, Suh KN, Wong A, Katz K, Wilkinson K, Mersereau T, Gravel D; Canadian Nosocomial Infection Surveillance Program (CNISP).

Epidemiol Infect. 2016 Mar;144(4):741-50. doi: 10.1017/S0950268815002113. Epub 2015 Sep 18.

43.

Management of Hepatocellular Carcinoma: Current Status and Future Directions.

Au JS, Frenette CT.

Gut Liver. 2015 Jul;9(4):437-48. doi: 10.5009/gnl15022. Review. Erratum in: Gut Liver. 2015 Nov 23;9(6):811.

44.

Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.

McDonald EG, Milligan J, Frenette C, Lee TC.

JAMA Intern Med. 2015 May;175(5):784-91. doi: 10.1001/jamainternmed.2015.42.

PMID:
25730198
45.

Novel low-resource intervention reduces urinary catheter use and associated urinary tract infections: role of outcome measure bias?

Schwartz BC, Frenette C, Lee TC, Green L, Jayaraman D.

Am J Infect Control. 2015 Apr 1;43(4):348-53. doi: 10.1016/j.ajic.2014.12.006. Epub 2015 Feb 10.

PMID:
25681304
46.

Antibiotic self-stewardship: trainee-led structured antibiotic time-outs to improve antimicrobial use.

Lee TC, Frenette C, Jayaraman D, Green L, Pilote L.

Ann Intern Med. 2014 Nov 18;161(10 Suppl):S53-8. doi: 10.7326/M13-3016.

PMID:
25402404
47.

Reply to Vanhems et al.

Taylor G, Mitchell R, McGeer A, Frenette C, Suh KN, Wong A, Katz K, Wilkinson K, Amihod B, Gravel D; Canadian Nosocomial Infection Surveillance Program.

Infect Control Hosp Epidemiol. 2014 Aug;35(8):1075. doi: 10.1086/677168. No abstract available.

PMID:
25026632
48.

Survey of infection control practices in hemodialysis units: preventing vascular access-associated bloodstream infections.

Trépanier P, Quach C, Gonzales M, Fortin E, Kaouache M, Desmeules S, Rocher I, Ngenda-Muadi M, Frenette C, Tremblay C; Quebec Healthcare-Associated Infections Surveillance Program Hemodialysis Group.

Infect Control Hosp Epidemiol. 2014 Jul;35(7):833-8. doi: 10.1086/676862. Epub 2014 May 8.

PMID:
24915211
49.

Building the multidisciplinary team for management of patients with hepatocellular carcinoma.

Naugler WE, Alsina AE, Frenette CT, Rossaro L, Sellers MT.

Clin Gastroenterol Hepatol. 2015 May;13(5):827-35. doi: 10.1016/j.cgh.2014.03.038. Epub 2014 Jun 5. Review.

PMID:
24909910
50.

Current management of hepatocellular carcinoma.

Crissien AM, Frenette C.

Gastroenterol Hepatol (N Y). 2014 Mar;10(3):153-61.

Supplemental Content

Loading ...
Support Center